{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:32:03Z","timestamp":1786480323345,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["RO1 DK133401"],"award-info":[{"award-number":["RO1 DK133401"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["RO1 DK133401"],"award-info":[{"award-number":["RO1 DK133401"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Understanding how heme proteins\/heme induce AKI and whether NAD\n                            <jats:sup>+<\/jats:sup>\n                            -boosting ameliorates heme protein\u2013mediated AKI is clinically relevant.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Heme proteins\/heme directly decrease kidney NAD\n                            <jats:sup>+<\/jats:sup>\n                            content and NAD\n                            <jats:sup>+<\/jats:sup>\n                            -boosting is markedly protective in heme protein\u2013mediated AKI.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            These findings provide new insights in heme protein\u2013mediated AKI and support interest in NAD\n                            <jats:sup>+<\/jats:sup>\n                            -boosting as a therapeutic strategy in AKI.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Understanding how heme proteins and heme induce AKI is clinically relevant from numerous perspectives, and, in this regard, a widely used model of heme protein\u2013mediated AKI (HP-AKI) involves the glycerol model in mice. Using this model, we have previously demonstrated that NAD\n                      <jats:sup>+<\/jats:sup>\n                      content is decreased in HP-AKI. Because there is significant current interest in NAD\n                      <jats:sup>+<\/jats:sup>\n                      -boosting as a strategy in clinical AKI, we examined the effect of NAD\n                      <jats:sup>+<\/jats:sup>\n                      -boosting in this model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      NAD\n                      <jats:sup>+<\/jats:sup>\n                      -boosting was achieved by the administration of nicotinamide mononucleotide (NMN) in the glycerol model of HP-AKI. The effect of NMN, compared with vehicle, was examined in mice with HP-AKI and with sham AKI at day 1 after HP-AKI was induced.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The administration of NMN preserved kidney NAD\n                      <jats:sup>+<\/jats:sup>\n                      content in HP-AKI, and compared with the administration of vehicle in HP-AKI, NMN improved glomerular filtration markers; reduced histologic injury as assessed by tubular necrosis, dilation, and cast formation and by assessment of dystrophic calcification; reduced expression of kidney injury marker 1, a sensitive marker of AKI; preserved mitochondrial ultrastructure and increased expression of proteins that promote mitochondrial integrity; reduced apoptosis as assessed by terminal deoxynucleotidyl transferase\u2013mediated digoxigenin-deoxyuridine nick-end labeling staining and genes and protein expression that contribute to apoptosis, while increasing expression of an anti-apoptotic gene; reduced expression of several renal injury-related genes; and mitigated the severity of the senescence phenotype, as assessed by multiple markers. Finally, the administration of myoglobin or heme\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      diminished kidney NAD\n                      <jats:sup>+<\/jats:sup>\n                      content in mice with intact kidneys.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings demonstrate the remarkable protective effects of NAD\n                      <jats:sup>+<\/jats:sup>\n                      -boosting by NMN in HP-AKI as revealed by a multitude of markers relevant to AKI. The reduction in NAD\n                      <jats:sup>+<\/jats:sup>\n                      content in the kidney in HP-AKI may reflect the direct effects of heme proteins and\/or heme. We suggest that these findings support current interest in NAD\n                      <jats:sup>+<\/jats:sup>\n                      -boosting as a therapeutic strategy in clinical AKI.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000001032","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T17:00:23Z","timestamp":1764090023000},"page":"475-486","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["NAD+-Boosting Ameliorates Heme Protein\u2013Mediated Acute Kidney Injury"],"prefix":"10.34067","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-2722","authenticated-orcid":false,"given":"Raman Deep","family":"Singh","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Croatt","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5674-1682","authenticated-orcid":false,"given":"Joseph P.","family":"Grande","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan W.","family":"Ackerman","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4862-6259","authenticated-orcid":false,"given":"Trace A.","family":"Christensen","sequence":"additional","affiliation":[{"name":"Microscopy and Cell Analysis Core Facility, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4630-2747","authenticated-orcid":false,"given":"Luis A.","family":"Juncos","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas"},{"name":"Medical Affairs, FME Global Medical Office Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-5506","authenticated-orcid":false,"given":"Karl A.","family":"Nath","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"1","key":"B1-20260330","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch","year":"2009","journal-title":"N Engl J Med."},{"issue":"7","key":"B2-20260330","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2215\/CJN.00850122","article-title":"The pathophysiology of sepsis-associated AKI","volume":"17","author":"Kuwabara","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B3-20260330","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.semnephrol.2020.01.006","article-title":"The role of circulating cell-free hemoglobin in sepsis-associated acute kidney injury","volume":"40","author":"Kerchberger","year":"2020","journal-title":"Semin Nephrol."},{"issue":"11","key":"B4-20260330","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.34067\/KID.0005442022","article-title":"Heme proteins and kidney injury: beyond rhabdomyolysis","volume":"3","author":"Nath","year":"2022","journal-title":"Kidney360."},{"issue":"1","key":"B5-20260330","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-3565(25)10290-5","article-title":"Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia\/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32","volume":"264","author":"Maines","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"issue":"4","key":"B6-20260330","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ki.1995.414","article-title":"Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat","volume":"48","author":"Agarwal","year":"1995","journal-title":"Kidney Int."},{"issue":"2","key":"B7-20260330","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1681\/ASN.2006080894","article-title":"Physiology and pathophysiology of heme: implications for kidney disease","volume":"18","author":"Tracz","year":"2007","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B8-20260330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/01.RES.38.4.267","article-title":"The vascular basis for acute renal failure in the rat. Preglomerular and postglomerular vasoconstriction","volume":"38","author":"Venkatachalam","year":"1976","journal-title":"Circ Res."},{"issue":"1","key":"B9-20260330","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1523-1755.1998.00731.x","article-title":"Intracellular targets in heme protein-induced renal injury","volume":"53","author":"Nath","year":"1998","journal-title":"Kidney Int."},{"issue":"5","key":"B10-20260330","doi-asserted-by":"crossref","first-page":"F676","DOI":"10.1152\/ajprenal.00061.2025","article-title":"ACE2 deficiency protects against heme protein-induced acute kidney injury","volume":"328","author":"Croatt","year":"2025","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6","key":"B11-20260330","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1681\/ASN.2014040320","article-title":"Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury","volume":"26","author":"Belliere","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B12-20260330","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nm.4462","article-title":"Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury","volume":"24","author":"Okubo","year":"2018","journal-title":"Nat Med."},{"issue":"4","key":"B13-20260330","doi-asserted-by":"crossref","first-page":"501","DOI":"10.34067\/KID.0000000000000395","article-title":"Induction of p16Ink4a gene expression in heme protein-induced AKI and by heme: Pathophysiologic implications","volume":"5","author":"Nath","year":"2024","journal-title":"Kidney360."},{"issue":"4","key":"B14-20260330","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ki.1980.156","article-title":"Renal tubular function in glycerol-induced acute renal failure","volume":"18","author":"Westenfelder","year":"1980","journal-title":"Kidney Int."},{"issue":"1","key":"B15-20260330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1172\/JCI115847","article-title":"Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat","volume":"90","author":"Nath","year":"1992","journal-title":"J Clin Invest."},{"issue":"10","key":"B16-20260330","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1172\/JCI67867","article-title":"Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury","volume":"123","author":"Zarjou","year":"2013","journal-title":"J Clin Invest."},{"issue":"21","key":"B17-20260330","doi-asserted-by":"crossref","first-page":"9833","DOI":"10.1073\/pnas.88.21.9833","article-title":"Role of glutathione in an animal model of myoglobinuric acute renal failure","volume":"88","author":"Abul-Ezz","year":"1991","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"B18-20260330","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ki.1995.75","article-title":"Heme protein-mediated renal injury: a protective role for 21-aminosteroids in vitro and in vivo","volume":"47","author":"Nath","year":"1995","journal-title":"Kidney Int."},{"issue":"10","key":"B19-20260330","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.34067\/KID.0004832022","article-title":"Prominent mitochondrial injury as an early event in heme protein-induced acute kidney injury","volume":"3","author":"Singh","year":"2022","journal-title":"Kidney360."},{"issue":"9","key":"B20-20260330","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41591-018-0138-z","article-title":"De novo NAD(+) biosynthetic impairment in acute kidney injury in humans","volume":"24","author":"Poyan Mehr","year":"2018","journal-title":"Nat Med."},{"issue":"8","key":"B21-20260330","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1681\/ASN.2016040385","article-title":"Nicotinamide mononucleotide, an NAD(+) precursor, rescues age-associated susceptibility to AKI in a sirtuin 1-dependent manner","volume":"28","author":"Guan","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B22-20260330","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s12013-024-01619-9","article-title":"\u03b2-Nicotinamide mononucleotide alleviates sepsis-associated acute kidney injury by activating NAD+\/SIRT3 signaling","volume":"83","author":"Sun","year":"2025","journal-title":"Cell Biochem Biophys."},{"issue":"2","key":"B23-20260330","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41581-019-0216-6","article-title":"NAD(+) homeostasis in renal health and disease","volume":"16","author":"Ralto","year":"2020","journal-title":"Nat Rev Nephrol."},{"issue":"3","key":"B24-20260330","doi-asserted-by":"crossref","first-page":"151287","DOI":"10.1016\/j.semnephrol.2022.10.013","article-title":"The significance of NAD+ biosynthesis alterations in acute kidney injury","volume":"42","author":"Clark","year":"2022","journal-title":"Semin Nephrol."},{"issue":"7","key":"B25-20260330","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.molmed.2024.12.004","article-title":"NAD(+) metabolism in acute kidney injury and chronic kidney disease transition","volume":"31","author":"Alhumaidi","year":"2025","journal-title":"Trends Mol Med."},{"issue":"3","key":"B26-20260330","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sj.ki.5001565","article-title":"Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues","volume":"70","author":"Nath","year":"2006","journal-title":"Kidney Int."},{"issue":"5","key":"B27-20260330","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","article-title":"Mitochondrial quality control in kidney injury and repair","volume":"17","author":"Tang","year":"2021","journal-title":"Nat Rev Nephrol."},{"issue":"1","key":"B28-20260330","doi-asserted-by":"crossref","first-page":"F4","DOI":"10.1152\/ajprenal.00275.2023","article-title":"Cell death induced by acute renal injury: a perspective on the contributions of accidental and programmed cell death","volume":"327","author":"Noh","year":"2024","journal-title":"Am J Physiol Renal Physiol."},{"issue":"5","key":"B29-20260330","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1681\/ASN.2015070740","article-title":"Cellular and molecular mechanisms of AKI","volume":"27","author":"Agarwal","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"B30-20260330","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.34067\/KID.0001302020","article-title":"Hypoxia-inducible factor and oxygen biology in the kidney","volume":"1","author":"Sugahara","year":"2020","journal-title":"Kidney360."},{"issue":"2","key":"B31-20260330","first-page":"209","article-title":"Induction of clusterin in acute and chronic oxidative renal disease in the rat and its dissociation from cell injury","volume":"71","author":"Nath","year":"1994","journal-title":"Lab Invest."},{"issue":"1","key":"B32-20260330","doi-asserted-by":"crossref","first-page":"e3000599","DOI":"10.1371\/journal.pbio.3000599","article-title":"A proteomic atlas of senescence-associated secretomes for aging biomarker development","volume":"18","author":"Basisty","year":"2020","journal-title":"PLoS Biol."},{"issue":"7","key":"B33-20260330","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1681\/ASN.0000000659","article-title":"Toward noninvasive biomarkers of renal senescence","volume":"36","author":"Baird","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B34-20260330","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.ekir.2025.04.035","article-title":"Urinary clusterin is a biomarker of renal epithelial senescence and predicts human kidney disease progression","volume":"10","author":"Baird","year":"2025","journal-title":"Kidney Int Rep."},{"key":"B35-20260330","doi-asserted-by":"crossref","first-page":"111376","DOI":"10.1016\/j.nut.2021.111376","article-title":"Nicotinamide retains Klotho expression and ameliorates rhabdomyolysis-induced acute kidney injury","volume":"91-92","author":"Lin","year":"2021","journal-title":"Nutrition."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:03:39Z","timestamp":1786478619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000001032","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"2025-08-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}